Objective: To determine the feasibility of a detailed pain sensitivity assessment using body-wide musculoskeletal tender points (TPs) in women with different types of chronic pelvic pain (CPP) and compare phenotypic differences.
C
hronic pelvic pain (CPP) affects as many as 15% of women in the United States at some time in their lives, with annual medical costs estimated at $2.8 billion (US) in 1996. 1, 2 CPP is characterized as persistent pain in the pelvic region perceived to arise from the gynecologic, urologic, gastrointestinal, and/or musculoskeletal systems. Common and frequently coexisting CPP conditions include myofascial pelvic pain (MPP) and bladder pain syndrome (BPS). Typically presenting with symptoms of dyspareunia or lower abdominal pelvic pain, women with MPP have myofascial tender points (TPs) in the muscles of the pelvic floor upon physical examination. BPS is a chronic idiopathic visceral pain syndrome with symptoms of chronic (> 6 mo) pelvic pain featuring pressure or discomfort related to urinary bladder fullness and persistent urinary urgency or frequency. 3 The high prevalence (78% to 87%) of concomitant myofascial pain, frequently extending beyond the anatomic boundaries of the pelvis in women with BPS, 4, 5 suggests these 2 disorders may share a common pathophysiology. In addition, almost a quarter of women with CPP have musculoskeletal abnormalities, 6 yet comprehensive musculoskeletal examination is seldom considered during medical evaluation. 7, 8 One might conceive several ways for muscle to become painful in patients with BPS. Muscle involvement could occur in response to bladder inflammation in a type of visceral or cross-organ somatic cosensitization. 9 Muscle could also constitute the primary source of pain and entrain changes in bladder function. 10, 11 Finally, both muscle and bladder could reflect a third deeper pathophysiological change, such as a neural network alteration or an immunologic process. These and other mechanisms could also occur in combination or differ across individuals. Consensus guidelines for the management of CPP created in 2005 highlighted the need for a better understanding of myofascial dysfunction. 12 Although body-pain mapping based on pain symptom questionnaires has revealed multiple symptoms in other body locations in women with BPS, 13 there is clear need to establish an objective, standardized musculoskeletal evaluation in women with CPP.
Our overarching hypothesis is that detailed examination of musculoskeletal pain sensitivity in different anatomic regions in patients with CPP can help to classify patients into potentially meaningful distinct subgroups. For example, involvement of body areas far removed from the pelvis suggests a generalized abnormality of central nervous system processing, whereas more restricted involvement of regions near the pelvis might imply more local changes. The present study aimed to (1) determine the feasibility of a detailed pain sensitivity assessment using musculoskeletal TPs in various body locations in women with CPP; and (2) compare possible phenotypic differences and correlations between body locations in patients with MPP or BPS to healthy controls (HC) to generate hypotheses regarding their pathophysiology.
MATERIALS AND METHODS
This study was approved by the University Hospitals Case Medical Center Institutional Review Board (Cleveland, Ohio). Women (18 to 78 y) with CPP and HCs consented for participation in this study (February 2011 to January 2014), part of the Interstitial Cystitis: Elucidation of Psychophysiologic and Autonomic Characteristics study (ICEPAC; ClinicalTrials.gov Identifier: NCT01616992). ICEPAC is a comprehensive, interdisciplinary approach to evaluation of women with MPP and BPS. The multidisciplinary team conducting the study consisted of a psychologist, urologist, gynecologist, urogynecologist, anesthesiologist, and neurologist. Specific details and methods of the study have been published. 14 In summary, women with BPS, MPP, BPS + MPP, and HCs underwent detailed examination to elucidate the role of central and peripheral nervous system processing in CPP. The evaluation consisted of a structured neurological examination of limbs and pelvis, TP examination, autonomic testing, electrogastrography, and assessment of comorbid functional dysautonomias, assessments of stress and response to it, trauma history, and general psychological function. All patients also underwent detailed assessment of pelvic pain symptoms, voiding patterns, gynecologic history, prior and current treatments, and present comorbidities. The primary aim of the work presented herein was to determine the feasibility and utility of a detailed pain sensitivity assessment using body-wide musculoskeletal TPs examination in women with different types of CPP and compare phenotypic differences of whole-body TP assessment among the groups. The primary outcome was a TP pain assessment based on a standardized numeric rating scale (NRS) pain score, with 0 meaning "pressure only" and 10 defined as "worst pain imaginable."
Patients were recruited from clinical practices and pelvic pain clinic. In addition, we advertised the study through the Interstitial Cystitis Association and Interstitial Cystitis Network. Patients were enrolled and categorized into one of the groups according to study definitions for each group when our screening evaluation confirmed the inclusion criteria. Patient screening included a pelvic floor examination and assessment of bladder pain symptoms. With the exception of a few patients recruited from an examiner's own clinic, examiners were unaware of pelvic pain phenotype before examination with the results of examinations leading to patient grouping. Inclusion criteria for study and patient classification were based on recommendations from our advisory board and evidence from available literature. Currently, there is no accepted definition or standardized means of examination for the presence of MPP. 15 We included patients into the MPP group when they reported at least 3 months of noncyclic CPP unrelated to bladder filling or emptying and a minimum NRS pain score of at least 4 of 10 using 2 kg pressure applied with the index finger onto at least 2 of 5 examined pelvic floor TPs. Pelvic floor TPs included bilateral levator ani (puborectalis) and obturator internus muscles and a single midline perineal assessment (Fig. 1) . We used the modified assessment validated by Zolnoun et al. 11 Initially, a pelvic muscle algometer was used for training purposes under direct supervision of Dr Zolnoun. This algometer has a pressure sensor capable of measuring a wide spectrum of force and allows direct and isolated palpation of pelvic floor musculature. Investigators practiced placing the desired pressure on the pelvic musculature using paid, healthy volunteers. After training, the examination of patients was performed without using the pressure sensor. Pressure was standardized against an algometer before each examination. Patients were included in the BPS group when they reported at least 6 months of urgency, frequency, and bladder pain clearly linked to bladder filling and emptying in accordance with 2008 European Society for the Study of Painful Bladder Syndrome recommendations. 3 Pelvic TPs played no role in this definition. As a large proportion of participants met criteria for both CPP disorders, they were classified as BPS + MPP. HCs were included when they had no history, symptoms or signs of fibromyalgia (FM), chronic fatigue syndrome, BPS, MPP, CPP, migraine headache, or any other putative BPS comorbid disorders and be age matched to within ± 3 years of a BPS + MPP patient. The exclusion criteria are presented in Table 1 .
Additional pelvic adjacent and body-wide TP pain assessments were conducted using specific pressures applied with an algometer, except where indicated, so that pressure could be directly monitored during assessments. Abdominal examination (10 TPs) included 3 kg pressure applied to rectus muscle midline (raphe) and lateral border muscle points (Fig. 2) . Palpation of the rectus muscles required the patient to actively lift their head while in the supine position. Inguinal ligaments (6 TPs total) were palpated bilaterally (3 kg) along their length including origin, midpoint, and insertion ( Fig. 2) . 16 Inner thigh evaluation (6 TPs total) included bilateral (3 kg) pain assessment in distal, mid, and proximal inner thigh (Fig. 2) . Eighteen FM TPs, as described by the American College of Rheumatology, 17 were palpated with the thumb using 4 kg of pressure. Although exerted pressure during the examination differed between body locations, we chose to apply the amount of pressure according to protocols that had been already published in the literature (4 kg for FM and 3 kg for abdominal and inguinal TPs). 16, 17 Our advisory board recommended a 2 kg pressure for pelvic muscle evaluation as there was a concern of examination tolerance in the context of myofascial pain.
Data were analyzed as follows. Age and body mass index were compared using 1-way ANOVA followed by Tukey's multiple comparisons test (GraphPad Prism version 6.1; GraphPad Software, La Jolla, CA). A final "TP pain score" was defined for each examination as the average of all TPs for that patient, that is, averages of pelvic floor, abdominal, inguinal, thigh, or FM TPs. Group mean TP scores were compared using the Mann-Whitney U test and pairwise group TP score correlations and 95% confidence intervals between regions were calculated in R 18 using the TP score and the logarithm of (TP score + 1). Pairwise group TP score correlations, using the TP score and the logarithm of (TP score + 1) were also calculated. As the BPS group was significantly older than the other 3 groups, we utilized a generalized linear model to evaluate age as a significant predictor of the pain TP scores in all 5 locations (pelvic floor, FM, groin, inner thighs, and abdomen). Correlations were considered to be weak, moderate, and strong with r < 0.3, 0.3 < r > 0.6, and r > 0.6, respectively. After screening, all patients completed the Multidimensional Pain Inventory, 19 a comprehensive measure of pain, function, and coping. 20 This questionnaire served as a covariate in the analysis to determine the impact of higher pain levels on pain correlations across body regions.
RESULTS
Following a screening examination for patient distribution based on pelvic pain, 105 women were grouped as follows: 11 MPP, 24 BPS, 35 BPS + MPP, and 35 HC. As shown in Table 2 , women with BPS alone tended to be older (F 3,101 = 4.513, P < 0.05) than other groups, whereas body mass index was similar (F 3,101 = 2.012, P = NS).
Mean TP scores in HC women were lower ( Fig. 3 , P < 0.001, all comparisons) than in CPP patients, whereas TP scores did not differ between women with MPP and those with BPS + MPP. By definition, women with MPP (MPP or BPS + MPP) had high pelvic floor TP pain, leading to significantly higher mean pelvic floor TP scores (P < 0.001) than did women with BPS alone. FM TP scores were 2.2 ± 1.8 (SD) in patients with BPS alone as compared with 3.7 ± 2.4 in BPS + MPP (P < 0.05) and 3.9 ± 2.4 in MPP (P = 0.05) (Appendix A). Although women with BPS or MPP alone had elevated inguinal, inner thigh, and abdominal TP scores compared with control, there was no difference between these 2 pain groups (P > 0.05). The combined group (BPS + MPP) had significantly more pain Table 3 Pairwise correlations of TP scores for all other body regions are shown in Table 4 . Data revealed moderate to strong positive correlations for TP scores between all body regions in the BPS + MPP group. The highest positive correlations were found between inguinal and abdominal TP regions in all 3 CPP groups.
DISCUSSION
Several findings from this study emerged. First, we were able to complete a structured musculoskeletal examination of TPs in various body locations in all study patients. This examination was feasible, tolerated by the patients, and provided a measure of deep tissue pain sensitivity in women with CPP. Second, women with CPP had significantly higher TP pain scores on musculoskeletal evaluation for all tested body regions when compared with HC. Third, careful phenotyping of women with CPP demonstrated differences in CPP subtypes, including patients with BPS alone, MPP alone, or both BPS and MPP together. Greater pain levels occurred in all body regions when BPS and MPP were present concomitantly. Although some moderate and strong correlations between different body location TPs were seen in all groups, only this BPS + MPP group consistently showed moderate to strong correlations between all body TPs, suggesting central sensitization as a more prominent feature in this group than in those with BPS alone.
This study reports on tender, not trigger, point assessment in CPP. TPs are defined as areas of tenderness occurring in the muscle, muscle-tendon junction, bursa, or fat pad. 21 As opposed to TPs, myofascial trigger points are characterized by point tenderness on a taut muscle band, local twitch response, referred pain in a different location reproduced by palpation of the trigger point, and restricted range of motion. 22, 23 MPP is not well defined in the existing literature. The frequent use of the terms "tender point" and Values are mean ± SD where applicable. *BPS group is older than all other groups (P < 0.05). BMI indicates body mass index; BPS, bladder pain syndrome; HC, healthy control; MPP, myofascial pelvic pain.
FIGURE 3. Image depicting mean tender point scores in different body locations for all study groups. Data are shown as group mean tender point scores with 95% confidence intervals for body regions ± SD. P < 0.001 when healthy controls are compared with BPS, MPP, and BPS + MPP in respective body locations. BPS indicates bladder pain syndrome; FM, fibromyalgia; MPP, myofascial pelvic pain.
"trigger point" interchangeably further complicates the definition of MPP. Given the prevalence of MPP in women, it would seem important to develop diagnostic criteria for this disorder. On the basis of available literature and our prior work, 11 we propose that MPP criteria include the following: (1) spontaneous chronic lower abdominal and/or pelvic pain for Z3 months; (2) pain worsened by stretching or pressure upon the pelvic muscles (eg, insertion of a tampon, a speculum, or intercourse); (3) tenderness upon palpation (2 kg of pressure; "moderate pressure" in a clinical setting) of at least 2 well-identified pelvic floor muscles with a NRS of Z4 on a 0 to 10 scale. The pelvic floor musculoskeletal examination did not extend the duration of the standard pelvic examination by more than a minute or 2 in our study. The presence or absence of another CPP disorder such as vulvodynia, endometriosis, or BPS does not conceptually influence the diagnosis of MPP, which may or may not be related to these other disorders. This definition has the advantage of simplicity and provides a relatively uniform basis for comparing patients with additional CPP diagnoses independently of one another. When defining MPP in as described, several properties of this syndrome emerge when compared with BPS. First, MPP is associated with higher TP pain scores in most areas of the body. Second, the correlation of pelvic floor TPs with FM TPs is moderate to strong (Table 4 ) and persists even when accounting for overall pain level, suggesting that a central driver for TPs may be present in MPP with or without concomitant BPS. Third, the highest TP pain scores occurred in the BPS + MPP group for inguinal, inner thigh, and abdominal TPs, but not for FM TPs. This more localized finding is consistent with a viscero-visceral-somatic hyperalgesia phenomenon where coexisting algogenic conditions in 2 internal organs in the same patient (bladder and muscle) enhance pain symptoms. 24 Although our findings are consistent with the previously reported high prevalence of levator muscle pain in women with bladder pain, 4,5 prior reports did not provide the same broad whole-body perspective by comparing TPs in other body locations. Tripp et al 13 implicitly considered BPS a subset of a more generalized pain disorder, but did not distinguish the subset with MPP. Using the symptom-based O'Leary Sant Patient Questionnaire to diagnose BPS, 25 the authors found that patients with BPS reported more pain in the thighs, abdominal region, back, and the posterior surface of the head compared with HC patients. As this questionnaire did not consider MPP and the study did not involve musculoskeletal examination, the distinction between the 2 disorders could not be evaluated. Thus, our findings extend and refine Tripp's concepts by including more precise phenotypic information and a clinical examination that delineates 3 separate pelvic pain subgroups.
The difference in TP pain severity between BPS and MPP (+ /À BPS) groups may have several explanations. Some of these differences are clearly definitional based on study-defined criteria. However, the lower TP scores for the FM examination in the BPS only group and the absence of a relationship between TP in the pelvis and FM body examination suggest some fundamental differences between BPS and MPP. The development of MPP in the context of BPS may signal the onset of central sensitization that is not present in isolated BPS, or may reflect difference in susceptibility to pain. Longitudinal studies will be required to determine if such an evolution occurs or if the phenotypic distinctions remain constant throughout the life of the disorders. If the advent of MPP signals central sensitization, one would predict greater generalized hyperalgesia in this patient group. Several reports describe decreased pain threshold (increased generalized hyperalgesia) or central sensitization with altered pain control in response to stimuli in different body locations in women with CPP with unknown MPP status. [26] [27] [28] [29] [30] Lai et al 27 found the presence of segmental hyperalgesia (suprapubic area) in the patients with BPS without FM TPs as compared with age-matched HCs. The reduction of pain thresholds in chronic musculoskeletal (including low back) pain suggests generalized hypersensitivity. 26 Thus, if myofascial pain reflects reduction in pain threshold, it may drive or reflect central hyperalgesia and altered responses to pain stimuli in women with BPS.
The cause of the body-wide TPs remains unclear. Because they occur so diffusely, one may reasonably presume dysfunction of central nervous system pathways responsible for pain modulation. However, it is possible This study has several limitations. The subgroup consisting of women with only MPP is small and important differences in this group may not be readily apparent. Given the lack of previously defined clinical criteria for MPP, the criteria proposed herein may require further refinement. Our study protocol allowed participants to continue their pain medication treatment regimen to optimize recruitment. Although this approach may have impacted pain measurements, it does not differentiate the groups and represents "real-life," reproducible assessment of CPP. Examination methodologies were standardized by our study advisory board and investigators. Applied pressure to different body locations differed as we combined the protocols evaluating myofascial pain from different published protocols. Multiple investigators performed examinations and, as such, data could be patient to examiner bias. Although a single neurologist with expertise in pain quantification trained all examiners, interexaminer reliability was not evaluated. Finally, our cross-sectional study design does not allow any inference regarding the critical questions of causation and chronology-does bladder pain lead to TPs or vice versa, etc. Cross-sectional design also limits our assessment of true duration of pain because of recall bias. We selected the abdominal and adductor muscle points because they are muscular and therefore similar to the pelvic muscle TPs, whereas the inguinal points are tendinous, and therefore more similar to the FM points which frequently occur in tendinous insertion areas. We do not know whether these are different or not from a pathophysiological perspective.
Data presented herein underscore the importance of a broad musculoskeletal TP evaluation. On the basis of our study, musculoskeletal evaluation of women with CPP is feasible, well tolerated by patients, and could be performed by a general obstetrician-gynecologist or specialist when evaluating women with CPP. If coexisting myofascial pain sensitivity (a possible sign of sensitization) is detected in patients diagnosed with BPS, the provider may want to consider approaches beyond those focused on the bladder or pelvic floor, such as whole-body physical therapy, exercise programs designed to promote physical reconditioning, or other evidence-based approaches to treating generalized pain syndromes such as cognitive-behavior therapy or tricyclic agents. (11) 5.8 ± 2.2 3.9 ± 2.4 4.6 ± 2.5 4.1 ± 3. Data are shown as group mean tender point pain scores for body region ± SD.
BPS indicates bladder pain syndrome; FM, fibromyalgia; HC, healthy control; MPP, myofascial pelvic pain.
